Phase I data on a “novel herbal therapy”

There is some media buzz around publication of the results of a Phase I trial of Zyflamend, a commercially available herbal concoction that is supposed to be able to “affect the inflammation responses and may serve an important function in promoting normal cell growth in the colon, pancreas, breast tissue, and other organ systems.” However, this information is not particularly new. … READ MORE …